Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 14;24(1):121.
doi: 10.1186/s12906-024-04428-y.

Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database

Affiliations

Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database

Keita Oura et al. BMC Complement Med Ther. .

Abstract

Background: Drug-induced interstitial lung disease (DIILD) is a severe adverse event leading to morbidity and mortality. This study evaluated the adverse event indicators of DIILD and time-to-onset profiles following the daily intake of herbal drugs (Scutellariae radix ["ogon" in Japanese], Bupleuri radix ["saiko" in Japanese], and Pinelliae tuber ["hange" in Japanese]) using the Japanese Adverse Drug Event Report database. DIILD was defined in accordance with the Medical Dictionary for Regulatory Activities.

Methods: The Japanese Adverse Drug Event Report database contained 830,079 reports published between April 2004 and April 2023. The association between herbal medicines and DILLD was evaluated using the pharmacovigilance index as the reporting odds ratio (ROR), logistic regression models, propensity score-matching techniques, and Weibull shape parameters.

Results: The adjusted RORs using multivariate logistic regression models for Scutellariae radix (daily intake), Pinelliae tuber (daily intake), sex (male), age (≥ 60 years), Scutellariae radix (daily intake)*age (≥ 60 years), and Scutellariae radix (daily intake)* Pinelliae tuber (daily intake) were 1.47 (1.36 - 1.59), 1.05 (1.01 - 1.10), 1.45 (1.34 - 1.57), 1.92 (1.74 - 2.11), 3.35 (3.12 - 3.60), and 1.49 (1.46 - 1.53), respectively. DIILD onset profiles were evaluated using the Weibull shape parameter. A logistic plot of daily intake and onset of DIILD was drawn. ROR signals were detected in 32 of 54 herbal medicines, including Scutellariae radix, Bupleuri radix, and Pinelliae tuber. The median duration (days) (interquartile range) to DIILD onset was 36.0 (27.0-63.0) for Saikokaryukotsuboreito, 35.0 (21.0-55.0) for Saireito, and 31.0 (13.5-67.5) for Shosaikoto. The Weibull shape parameter beta (95% confidence interval) values for Saikokaryukotsuboreito, Saireito, and Shosaikoto were 1.36 (1.08-1.67), 1.36 (1.20-1.52), and 1.31 (0.98-1.68), respectively.

Conclusions: DIILD demonstrated a dose-dependent to crude drugs. Clinicians should strive for the early detection of DIILD and avoid the inadvertent administration of herbal medicines.

Keywords: Drug-induced interstitial lung disease; Herbal medicine; JADER; Japanese Adverse Drug Event Report database; Scutellariae radix.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of data analysis
Fig. 2
Fig. 2
Two-by-two used for the calculation of the reporting odds ratio
Fig. 3
Fig. 3
Logistic plots of daily intake (gram per day) and the onset of drug-induced interstitial lung disease (yes = 1, no = 0)
Fig. 4
Fig. 4
Receiver operating characteristic curve of SR, BR, and PT
Fig. 5
Fig. 5
Time-to-onset profiles of drug-induced interstitial lung disease
Fig. 6
Fig. 6
Kaplan–Meier curve plot for each group (SR, BR, PT, SR_BR, SR_PT, and SR_BR_PT)

Similar articles

Cited by

References

    1. Schwaiblmair M, Behr W, Haeckel T, Märkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J. 2012;6:63–74. doi: 10.2174/1874306401206010063. - DOI - PMC - PubMed
    1. Ministry of Health, Labour and Welfare. The manual for handling disorders due to adverse drug reactions, interstitial lung disease. 2019. https://www.mhlw.go.jp/topics/2006/11/tp1122-1b.html. Accessed 15 Jun 2022.
    1. Podolanczuk AJ, Wong AW, Saito S, Lasky JA, Ryerson CJ, Eickelberg O. Update in Interstitial lung disease 2020. Am J Respir Crit Care Med. 2021;203:1343–1352. doi: 10.1164/rccm.202103-0559UP. - DOI - PMC - PubMed
    1. Matsumoto K, Nakao S, Hasegawa S, Matsui T, Shimada K, Mukai R, et al. Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database. SAGE Open Med. 2020;8:2050312120918264. doi: 10.1177/2050312120918264. - DOI - PMC - PubMed
    1. Tsutani K. Kusuri ha risuku : Kampoyaku kara seiyoyaku wo miru. Jpn J Pharmacoepidemiol. 2010;15:31.